.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Covington
Julphar
Baxter
Farmers Insurance
Dow
Boehringer Ingelheim
Fuji
Cipla

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020123

« Back to Dashboard

NDA 020123 describes OMNISCAN, which is a drug marketed by Ge Healthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the OMNISCAN profile page.

The generic ingredient in OMNISCAN is gadodiamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.

Summary for 020123

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 020123

Suppliers and Packaging for NDA: 020123

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OMNISCAN gadodiamide INJECTABLE;INJECTION 020123 NDA GE Healthcare Inc. 0407-0690 0407-0690-15 10 VIAL in 1 BOX (0407-0690-15) > 15 mL in 1 VIAL
OMNISCAN gadodiamide INJECTABLE;INJECTION 020123 NDA GE Healthcare Inc. 0407-0690 0407-0690-20 10 VIAL in 1 BOX (0407-0690-20) > 20 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength287MG/ML
Approval Date:Jan 8, 1993TE:RLD:Yes

Expired Orange Book Patents for NDA: 020123

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareOMNISCANgadodiamideINJECTABLE;INJECTION020123-001Jan 8, 1993► Subscribe► Subscribe
Ge HealthcareOMNISCANgadodiamideINJECTABLE;INJECTION020123-001Jan 8, 1993► Subscribe► Subscribe
Ge HealthcareOMNISCANgadodiamideINJECTABLE;INJECTION020123-001Jan 8, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chubb
Farmers Insurance
US Department of Justice
Johnson and Johnson
Medtronic
Boehringer Ingelheim
McKinsey
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot